SPC
COLL icon

Sigma Planning Corp’s Collegium Pharmaceutical COLL Stock Holding History

Sigma Planning Corp’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,000
Closed -$370K – 1335
2025
Q4 		$370K Buy
+8,000
New +$335K 0.01% 926

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Sigma Planning Corp's COLL Position: Q1 2026 in Review

Sigma Planning Corp sold out of Collegium Pharmaceutical (COLL) in Q1 2026, closing a stake of 8,000 shares — an estimated $370K sold.

Sigma Planning Corp first reported a position in COLL in Q4 2025 and held it in 1 quarter. The position peaked at $370K in Q4 2025. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • Sigma Planning Corp reported no remaining Collegium Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Sigma Planning Corp sold 8,000 Collegium Pharmaceutical shares in Q1 2026, an estimated $370K.
  • Sigma Planning Corp first reported a position in Collegium Pharmaceutical in Q4 2025 and held it in 1 quarter.
  • Sigma Planning Corp's Collegium Pharmaceutical position peaked at $370K in Q4 2025.
  • 266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Sigma Planning Corp's 13F filing for Q1 2026, filed 4 May 2026.